Key result
CMR provides radiation-free diagnostic and prognostic evaluation of cardiac sarcoidosis.
Why the study?
Sarcoidosis carries high morbidity and substantial mortality, and cardiovascular magnetic resonance imaging has emerged as an important diagnostic and prognostic modality for cardiac involvement.
What is the role of cardiovascular magnetic resonance imaging in the diagnosis and management of cardiac sarcoidosis?
What is the role of cardiovascular magnetic resonance imaging in the diagnosis and management of cardiac sarcoidosis?
CMR is a key imaging modality for diagnosing and managing cardiac sarcoidosis due to its high resolution and lack of ionizing radiation.
Supports CMR as radiation-free option for cardiac sarcoidosis evaluation; leaves open need for prospective trials before guideline integration.
Sarcoidosis is a relatively rare inflammatory condition which potentially carries high morbidity and substantial mortality. Due to the fact that it does not subject patients to ionizing radiation, has high temporal, spatial and contrast resolutions, cardiovascular magnetic resonance imaging (CMR) has become an important diagnostic and prognostic modality in the evaluation for cardiac involvement in this condition. This review provides relevant clinical and pathophysiological background on cardiac sarcoidosis, whilst detailing the role of CMR imaging in the diagnosis, and management of this condition.
No takes yet. Share an insight, caveat, or question.
Smedema et al. (2020) conducted a review in Cardiac sarcoidosis. Cardiovascular magnetic resonance imaging (CMR) was evaluated. Cardiovascular magnetic resonance imaging (CMR) serves as an important diagnostic and prognostic modality for evaluating cardiac involvement in sarcoidosis without subjecting patients to radiation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: